Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy
WikiImages / Pixabay

Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

According to a story from news-medical.net, an international research team affiliated with the UK Medical Research Council, Indiana University School of Medicine, and the University of Kansas have released a…

Continue Reading Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year

According to a publication from Reuters, based on early clinical data, American biotechnology company BioMarin Pharmaceuticals believes that a single injection of its experimental hemophilia A drug could relieve symptoms…

Continue Reading Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year

ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols

According to a recent publication from BioPharma Dive, Dr. Janet Woodcock sat for an interview at the Biotechnology Innovation Organization's annual conference in Philadelphia earlier this month. Woodcock, the Director…

Continue Reading ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols

Legal and Ethical Questions: What is Pharma’s Obligation to Pursue Development of a Promising but Non-Profitable Drug?

  Dr. Craig Klugman, a bioethics professor at DePaul University, expresses his opinion in this recent article in Columbia University’s Bioethics.com. Dr. Klugman begins with a discussion of Pfizer’s biological drug,…

Continue Reading Legal and Ethical Questions: What is Pharma’s Obligation to Pursue Development of a Promising but Non-Profitable Drug?